- FDA initiates safety study of abortion pill mifepristone, official confirms
- Putin ally advocates for nuclear weapons in vision for Russia’s future
- EU leaders meet Western Balkan states to discuss membership bid progress
- US lawmakers reach tentative agreement to avert government shutdown
- Mogadishu clashes exacerbate Somalia’s ongoing political crisis
- High-water levels to raise Saskatoon waterline by over half a metre
- House approves new Ukraine aid package as several Republicans join Democrats
- Astronomers find evidence of magnetic fields on distant exoplanets with high-speed winds
UK public borrowing exceeds official forecast in September
FT.com Tweet
Government borrowing overshot official projections in September, which is a sign of the difficult fiscal position that the Chancellor faces as she puts the finishing touches on her first tax and spending budget.
CITY AM Tweet
Get you up to speed: FDA launches safety study for abortion pill mifepristone, source says
The Food and Drug Administration has initiated a safety study of the abortion pill mifepristone, as confirmed by a senior FDA official. The retrospective study will examine hundreds of thousands of cases, with interim results expected in July.
The Food and Drug Administration’s safety study of mifepristone will involve a retrospective analysis of hundreds of thousands of cases, with interim results expected in July. Meanwhile, the U.S. Supreme Court has temporarily allowed the delivery of mifepristone through the mail while legal challenges continue regarding its distribution.
The Food and Drug Administration has initiated a safety study of mifepristone, with interim results expected by July, which may inform future restrictions on the medication. This follows renewed scrutiny after the Biden administration eased access protocols, amid ongoing legal challenges, including a lawsuit from Louisiana that contested mifepristone’s mail delivery.
What remains unclear — The timeline for the final results of the FDA’s safety study on mifepristone has not been specified.
FDA initiates safety study of abortion pill mifepristone, official confirms
The Food and Drug Administration has launched a safety study of the abortion pill mifepristone, a senior FDA official confirmed to WTX US News, a step that could create a path for the Trump administration to restrict access to the medication.
It will be a retrospective study of hundreds of thousands of cases, according to the official. The interim results of the study could be released in July, but the official noted the timing of the final results will depend on the design of a secondary analysis after the interim results come in.
The Wall Street Journal was first to report on the launch of the study.
Last September, Health and Human Services Secretary Robert F. Kennedy Jr. wrote in a letter to several Republican state attorneys general that the FDA was reviewing the safety of mifepristone.
At the time, Kennedy and then-FDA Commissioner Martin Makary wrote, “HHS — through the FDA — is conducting its own review of the evidence, including real-world outcomes and evidence, relating to the safety and efficacy of the drug.”
Yet Makary came under scrutiny from some Congressional Republicans and anti-abortion groups who believed the agency was dragging its feet on the study under his watch for political reasons.
The drug came under renewed scrutiny after the Biden administration issued a memorandum lifting restrictions that required the drug to be dispensed in-person and giving access to mifepristone via telehealth and by mail.
Last year, the state of Louisiana filed a lawsuit challenging the FDA’s decision to allow mifepristone to be delivered by mail.
On May 4, the U.S. Court of Appeals for the 5th Circuit temporarily reinstated the rule requiring mifepristone to only be dispensed in person.
However, the following week, the Supreme Court set aside the lower court order and allowing, for now, mifepristone to continue to be delivered to patients through the mail while the Louisiana case plays out in the courts.
Mifepristone, which was first approved by the FDA in 2000 as a safe way to end early pregnancies, is typically taken with a second drug, misoprostol.
Asked last year whether a review of mifepristone could lead to a ban, WTX US News medical contributor Dr. Celine Gounder suggested it would be difficult for the FDA to withdraw approval, an extraordinary step that would quickly draw legal challenges.
However, Gounder said that depending on what the safety review finds, it could make access more difficult, limiting the drug’s availability through telehealth or by mail, or restricting the ability to prescribe it to doctors, rather than physician assistants or nurses who are also currently able to prescribe it.
Kathryn Watson and
Melissa Quinn
contributed to this report.
In:
Get you up to speed: Putin mouthpiece considers use of nuclear weapons to be a ‘good’ scenario for Russia | News World
Konstantin Malofeev and Alexander Dugin presented a report outlining a 25-year vision for Russia during the Petersburg International Economic Forum. Their comments included predictions of nuclear weapons use and geopolitical outcomes amidst ongoing sanctions from the UK, US, and EU.
Konstantin Malofeev’s report has been presented to the Ministry of Defence, outlining three potential futures for Russia, including significant military actions. The 29th St. Petersburg International Economic Forum, which runs from 3 to 6 June 2026, has revealed a divide in Russian thought regarding the ongoing conflict in Ukraine and its economic ramifications.
Konstantin Malofeev presented a report at the Petersburg International Economic Forum outlining a 25-year vision for Russia that includes potential nuclear actions to secure what he describes as a ‘good’ outcome. Both Malofeev and co-author Alexander Dugin, who have faced sanctions from the UK, US, and EU, indicated that the report has been submitted to the Ministry of Defence.
What remains unclear — It is not specified how the proposed nuclear strategy will align with international relations or the potential repercussions for Russia.
Putin ally advocates for nuclear weapons in vision for Russia’s future
A Putin ally has set out a 25-year vision for Russia that includes using nuclear weapons to secure what he calls a ‘good’ outcome.
Konstantin Malofeev, founder of Orthodox media network Tsargrad, made his comments while presenting a Russia 2050 report at the Petersburg International Economic Forum.
He predicted three possible outcomes:
Good: Russia ‘obtaining a clear image of victory in the ideological war’ using nuclear weapons, annexing major Ukrainian cities including Kyiv, Odesa and Kharkiv, and seeing the European Union fall
Bad: Russia losing the war in Ukraine and being colonised
Status quo: American or Chinese global dominance and Russia potentially using nuclear weapons within the next decade
Malofeev has been a vocal supporter of the annexation of Crimea and funded efforts to destabilise Ukraine, including backing Russia’s 2014 invasion against the country.
He was joined by co-author Alexander Dugin who who said the report had already been presented to the Ministry of Defence.
Sign up for all of the latest stories
Both men face sanctions from the UK, US and EU.
In its opening days, the summit, dubbed Putin’s Davos, has highlighted two competing schools of thought in Russia.

Alexander Dugin said the war in Ukraine ‘will end either with Russia’s victory or it will never end’ (Picture: EPA)
Some want the country to continue fighting and prepare for global confrontation with the West. Others have highlighted the economic benefits to be reaped from ending the war.
However, the conference was overshadowed when Ukrainian drones hit an oil terminal and naval base in St Petersburg.
Several prominent figures in Russia have tried in the past to warn Putin about the economic consequences of the war.
Kirill Dmitriev, Russia’s go-between with the Trump administration, has been touting the potential economic benefits of a peace deal.
‘The question is: does this war end or do we stare into a much tougher future?’ one Russian participant told Reuters.
Putin says Moscow does not intend to attack NATO, whose member states’ combined economies dwarf that of Russia, even though it is the world’s biggest supplier of natural resources.
But Mr Dugin, whose daughter Darya was killed in a 2022 car bomb that Moscow blamed on Ukraine, said the war in Ukraine ‘will end either with Russia’s victory or it will never end.’
He said: ‘We need to gather all our strength, gather all of our will and stop pretending that we are a peaceful country that goes off to barbecues or summer vacations.’
Dugin said Russia would not attack the West. But, asked to sum up Russia’s relations with the West in the coming years, he said simply: ‘War.’
Comment now
Comments
Add WTX as a Preferred Source on Google
What to Watch
Amazon prime - TV & Netflix
What to Watch
Love Sports
- Readers Digest
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.

